Clinical Trial Update: Metformin for Treatment Antipsychotic-induced Metabolic Syndrome in Bipolar Disorder Patients [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating metformin for antipsychotic-induced metabolic syndrome in bipolar disorder patients. The study, sponsored by China Medical Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: China Medical University, China | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED